CALL/ABBOTT LABORATORIES/155/0.1/21.06.24 Stock

Warrant

DE000GX8Z2Q8

Real-time BOERSE MUENCHEN 12:26:16 2024-06-10 EDT
0.002 EUR +100.00% Intraday chart for CALL/ABBOTT LABORATORIES/155/0.1/21.06.24
3 months-90.00%
6 months-80.00%
Date Price Change
24-06-10 0.002 +100.00%
24-06-07 0.001 0.00%
24-06-06 0.001 0.00%
24-06-05 0.001 0.00%
24-06-04 0.001 -50.00%

Real-time BOERSE MUENCHEN

Last update June 10, 2024 at 12:26 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Goldman Sachs
WKN GX8Z2Q
ISINDE000GX8Z2Q8
Date issued 2022-09-06
Strike 155 $
Maturity 2024-06-21 (11 Days)
Parity 10 : 1
Emission price 0.24
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.435
Lowest since issue 0.001
Spread 0.02
Spread %90.91%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
107.6 USD
Average target price
125.4 USD
Spread / Average Target
+16.54%
Consensus